MORTALITY FROM BREAST CANCER AMONG WOMEN BELOW 40 YEARS OLD
DOI:
https://doi.org/10.5380/ce.v19i3.34119Keywords:
Breast neoplasias, Hospital records, Nursing.Abstract
This is a descriptive documental study aiming
to investigate the epidemiological profile of the deaths
which occurred among women aged below 40 years
old, diagnosed with breast cancer. Data collection was
undertaken in the Hospital Records (Cancer) Service of
the Teaching Hospital of the Federal University of Paraná,
Brazil, including information recorded between January
2003 and December 2011. A total of 638 notifications
of breast cancer were identified, of which 68 were of
women aged below 40 years old, of whom 21 died. It
was ascertained that the survival was, on average, of 40
months; and that 76.2% were at advanced stages (III or
IV). It is emphasized that screening for breast cancer in
women at high risk allows the detection of tumors at earlier
stages, reducing the incidence in the number of deaths and
improving the health indicators.
Downloads
Published
How to Cite
Issue
Section
License
Cogitare Enfermagem reserves the right to make normative, orthographic, and grammatical changes to the published article to maintain the cultured standard of the language, while respecting the authors' style.
The published study is the sole responsibility of the author(s), and Cogitare Enfermagem is exclusively responsible for evaluating the manuscript as a scientific publication vehicle. Revista Cogitare Enfermagem is not responsible for any violations of Law No. 9,610/1998, the Brazilian Copyright Law.
Cogitare Enfermagem allows the author to hold the copyright of articles accepted for publication, without restrictions.
The articles published are licensed under the Creative Commons license CC BY 4.0 Creative Commons - Attribution 4.0 International - CC BY 4.0 - The attribution adopted by Cogitare Enfermagem is permitted:
- Share - copy and redistribute the material in any media or format.
- Adapt - remix, transform and build upon the material for any purpose, even commercially.
- Attribution - You must give proper credit, provide a link to the license, and indicate if changes have been made. You may do this in any reasonable way, but not in a way that suggests that the licensor endorses it or approves of its use.
- No additional restrictions - You may not apply legal terms or technological measures that legally restrict others from doing something that the license allows.




















